(Q33734263)

29 July 2017

title

Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study (English)

1 reference

29 July 2017

0 references

1 reference

1 reference

Ostergaard L

1

1 reference

29 July 2017

Werdelin L

2

1 reference

29 July 2017

Odin P

3

1 reference

29 July 2017

Lindvall O

4

1 reference

29 July 2017

Dupont E

5

1 reference

29 July 2017

Christensen PB

6

1 reference

29 July 2017

Boisen E

7

1 reference

29 July 2017

Jensen NB

8

1 reference

29 July 2017

Ingwersen SH

9

1 reference

29 July 2017

Schmiegelow M

10

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

29 July 2017

published in

1 reference

29 July 2017

volume

58

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

681-687

1 reference

Apomorphine in Parkinson's disease

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Subcutaneous apomorphine in Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

The short-duration response to apomorphine: implications for the mechanism of dopaminergic effects in parkinsonism.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Subcutaneous apomorphine in the treatment of Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Efficacy of sublingual apomorphine in Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Intranasal apomorphine: a new treatment in Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Intranasal apomorphine in Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Core assessment program for intracerebral transplantations (CAPIT)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Treatment of Parkinson's disease with aporphines. Possible role of growth hormone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Injected apomorphine and orally administered levodopa in Parkinsonism

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073544

Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS

30 October 2018

1 reference

12 December 2020

Apomorphine in Parkinsonian tremor

1 reference

12 December 2020

Cholinergic and dopaminergic mechanisms in Parkinson's disease after long term levodopa administration

1 reference

12 December 2020

"On-off" phenomena, dyskinesias and dystonias. Comparison of lisuride versus apomorphine acute treatment

1 reference

12 December 2020

Heart failure responding to octreotide in patient with acromegaly

1 reference

12 December 2020

Peripheral pharmacokinetics of apomorphine in humans

1 reference

12 December 2020

Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.58.6.681

1 reference

29 July 2017

1 reference

29 July 2017

1 reference